Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Small Cell Lung Carcinoma × osimertinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 140 Lung Neoplasms 45 Neoplasms 13 Neoplasm Metastasis 10 NSCLC 10 Brain Neoplasms 10 Carcinoma 8 Meningeal Carcinomatosis 6 Bronchial Neoplasms 5 Thoracic Neoplasms 4 Colorectal Neoplasms 4 Respiratory Tract Neoplasms 3 Respiratory Tract Diseases 3 Neoplasms by Site 3 Lung Diseases 3 Adenocarcinoma of Lung 3 Adenocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Noonan Syndrome 2 Non Small Cell Lung Cancer Metastatic 2 Neoplasms, Nerve Tissue 2 Neoplasms by Histologic Type 2 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Bronchogenic 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1

Interventions

Etoposide 136 Carboplatin 124 Cisplatin 93 Topotecan 66 durvalumab 46 Irinotecan 41 atezolizumab 40 pembrolizumab 32 Nivolumab 29 Radiotherapy 28 Paclitaxel 28 PM 01183 20 anlotinib 19 Drug Therapy 19 apatinib 18 Gemcitabine 18 Ipilimumab 17 Platinum 16 Docetaxel 15 olaparib 13 Radiosurgery 13 Bevacizumab 13 Pemetrexed 12 toripalimab 11 rovalpituzumab tesirine 10 amrubicin 10 Temozolomide 10 tremelimumab 9 tislelizumab 9 Magnetic Resonance Spectroscopy 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07153055 2025-12-18

LOTS

Indiana University

Phase 1/2 Not yet recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡